Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SEATRIUM LIMITED (5E2)

  • Business News
  • June 10, 2026, 11:30 UTC
  • 3
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Sarjit Singh Gill

Market reaction Comment Full text

ORGANON & CO. (OGN)

  • Business News
  • June 10, 2026, 11:30 UTC
  • 4
  • 1 comments

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

Market reaction Comment Full text

PAR TECHNOLOGY CORP (PAR)

  • Business News
  • June 10, 2026, 11:30 UTC
  • 4
  • 1 comments

Smoothie King Drives Incremental Revenue and Loyalty Engagement with PAR Games in First Three Months

Market reaction Comment Full text

LATAM AIRLINES GROUP S.A. (LTM)

  • Business News
  • June 10, 2026, 11:30 UTC
  • 3
  • 1 comments

LTM Introduces BlueVerse™ Currency to Enable Outcome-Based Pricing in the Agentic AI Era

Market reaction Comment Full text

SEATRIUM LIMITED (5E2)

  • Business News
  • June 10, 2026, 11:29 UTC
  • 3
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Ieda Gomes Yell

Market reaction Comment Full text

SEATRIUM LIMITED (5E2)

  • Business News
  • June 10, 2026, 11:28 UTC
  • 3
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Jan Holm

Market reaction Comment Full text

SEATRIUM LIMITED (5E2)

  • Business News
  • June 10, 2026, 11:28 UTC
  • 3
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Yap Chee Keong

Market reaction Comment Full text

SEATRIUM LIMITED (5E2)

  • Business News
  • June 10, 2026, 11:27 UTC
  • 3
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Mark Gainsborough

Market reaction Comment Full text

SEATRIUM LIMITED (5E2)

  • Business News
  • June 10, 2026, 11:26 UTC
  • 3
  • 0 comments

Employee Stock Option/ Share Scheme: Grant of Awards and Transfer and Use of Treasury Shares

Market reaction Comment Full text

CORE & MAIN, INC. (CNM)

  • Business News
  • June 10, 2026, 11:25 UTC
  • 4
  • 1 comments

Core & Main Announces Fiscal 2026 First Quarter Results

Market reaction Comment Full text
  • Previous
  • 2631
  • 2632
  • 2633
  • 2634
  • 2635
  • Next

Search

News categories

  • Technical Exchange News(14098)
  • Event(6229)
  • SEC News(359824)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(218343)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin